BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 36998215)

  • 1. Onset of an Active Charcot Foot in a Person with Longstanding Type 1 Diabetes and Normal Vibration Perception Threshold-A Case Report.
    Petrova NL; Banatwalla R; Hunt KF; Ahluwalia R; Elias DA; Bates M; Vas PRJ
    Int J Low Extrem Wounds; 2023 Mar; ():15347346231166550. PubMed ID: 36998215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of Charcot Foot: A Case Report.
    Phillips A; Rice L
    Nephrol Nurs J; 2022; 49(5):419-425. PubMed ID: 36332122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis and treatment of active charcot neuro-osteoarthropathy in persons with diabetes mellitus: A systematic review.
    Raspovic KM; Schaper NC; Gooday C; Bal A; Bem R; Chhabra A; Hastings M; Holmes C; Petrova NL; Santini Araujo MG; Senneville E; Wukich DK
    Diabetes Metab Res Rev; 2024 Mar; 40(3):e3653. PubMed ID: 37179484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcaneal bone mineral density in patients with Charcot neuropathic osteoarthropathy: differences between Type 1 and Type 2 diabetes.
    Petrova NL; Foster AV; Edmonds ME
    Diabet Med; 2005 Jun; 22(6):756-61. PubMed ID: 15910628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An atypical and bilateral presentation of Charcot foot disease.
    Loupa CV; Meimeti E; Kokas A; Voyatzoglou ED; Donou A
    BMC Endocr Disord; 2019 Sep; 19(1):96. PubMed ID: 31488114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early Treatment of Acute Stage 0/1 Diabetic Charcot Foot Can Avoid Major Amputations at One Year.
    Bittante C; Cerasari V; Bellizzi E; Ahluwalia R; Di Venanzio M; Giurato L; Andreadi A; Bellia A; Uccioli L; Lauro D; Meloni M
    J Clin Med; 2024 Mar; 13(6):. PubMed ID: 38541859
    [No Abstract]   [Full Text] [Related]  

  • 7. The prevalence of peripheral neuropathy severe enough to cause a loss of protective sensation in a population-based sample of people with known and newly detected diabetes in Barbados: a cross-sectional study.
    Adams OP; Herbert JR; Howitt C; Unwin N
    Diabet Med; 2019 Dec; 36(12):1629-1636. PubMed ID: 31094005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progression of foot deformity in Charcot neuropathic osteoarthropathy.
    Hastings MK; Johnson JE; Strube MJ; Hildebolt CF; Bohnert KL; Prior FW; Sinacore DR
    J Bone Joint Surg Am; 2013 Jul; 95(13):1206-13. PubMed ID: 23824389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Asymmetrical attenuation of vibration sensation in unilateral diabetic Charcot foot neuroarthropathy.
    Valabhji J; Marshall RC; Lyons S; Bloomfield L; Hogg D; Rosenfeld P; Gabriel CM
    Diabet Med; 2012 Sep; 29(9):1191-4. PubMed ID: 22276944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of protective sensory loss, neuropathy and foot ulceration in type 2 diabetes.
    Paisey RB; Darby T; George AM; Waterson M; Hewson P; Paisey CF; Thomson MP
    BMJ Open Diabetes Res Care; 2016; 4(1):e000163. PubMed ID: 27239314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Etiology, pathophysiology and classifications of the diabetic Charcot foot.
    Papanas N; Maltezos E
    Diabet Foot Ankle; 2013; 4():. PubMed ID: 23705058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic Signature for the Causation of Charcot Neuro-osteoarthropathy of Foot in Diabetes: A Systematic Review.
    Sharma S; Rastogi A
    Int J Low Extrem Wounds; 2024 May; ():15347346241252549. PubMed ID: 38711285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of thermal and vibration sensation in diabetic neuropathy.
    Guy RJ; Clark CA; Malcolm PN; Watkins PJ
    Diabetologia; 1985 Mar; 28(3):131-7. PubMed ID: 3996794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Charcot osteoarthropathy in type 2 diabetes persons presenting to specialist diabetes clinic at a tertiary care hospital.
    Younis BB; Shahid A; Arshad R; Khurshid S; Masood J
    BMC Endocr Disord; 2015 Jun; 15():28. PubMed ID: 26065885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Charcot Foot Reflects a Response to Injury That Is Critically Distorted by Preexisting Nerve Damage: An Imperfect Storm.
    Jeffcoate W; Game F
    Diabetes Care; 2022 Jul; 45(7):1691-1697. PubMed ID: 35796768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Charcot arthropathy of the foot and ankle associated with rheumatoid arthritis.
    Grear BJ; Rabinovich A; Brodsky JW
    Foot Ankle Int; 2013 Nov; 34(11):1541-7. PubMed ID: 23900228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective neuropathy and preserved vascular responses in the diabetic Charcot foot.
    Stevens MJ; Edmonds ME; Foster AV; Watkins PJ
    Diabetologia; 1992 Feb; 35(2):148-54. PubMed ID: 1547919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sympathetic neuropathy in diabetes mellitus patients does not elicit Charcot osteoarthropathy.
    Christensen TM; Simonsen L; Holstein PE; Svendsen OL; Bülow J
    J Diabetes Complications; 2011; 25(5):320-4. PubMed ID: 21813289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bilateral diabetic Charcot foot.
    Fauzi AA; Yang CT
    Aust Fam Physician; 2013; 42(1-2):55-6. PubMed ID: 23529463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guidelines on the diagnosis and treatment of active Charcot neuro-osteoarthropathy in persons with diabetes mellitus (IWGDF 2023).
    Wukich DK; Schaper NC; Gooday C; Bal A; Bem R; Chhabra A; Hastings M; Holmes C; Petrova NL; Santini Araujo MG; Senneville E; Raspovic KM
    Diabetes Metab Res Rev; 2024 Mar; 40(3):e3646. PubMed ID: 37218537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.